NCT07168941Recruiting
Evaluation and Refinement of KF-STRIDE Into the Interview!
Source: ClinicalTrials.gov · Last updated 28 Aug 2026
Brief summary (registry, in English)
Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 4 Sept 2025
- Start date
- 26 Jan 2026
- Primary completion date
- 1 Jan 2027
- Lead sponsor
- Kessler Foundation
- Diseases
- Autism
- NCT number
- NCT07168941
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 26 Jan 2026 to the primary completion date, 1 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants have a history of significant psychiatric illness (like bipolar disorder, schizophrenia, or psychosis)
- Participants have a history of substance abuse
Who the study is looking for
- Participants live in the United States of America
- Participants speak English Fluently and at a 4th grade reading level
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kessler Foundation Coordinator of this site? Confirm its status | East Hanover | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.